Arakis and Vectura to develop COPD therapy

Arakis ( Cambridge, U.K.) and Vectura (Bath, U.K.) will develop Arakis' AD 237 long acting inhaled bronchodilator formulation to treat chronic obstructive pulmonary disease (COPD). Vectura will formul...